Ilse de Bruin

Ilse de Bruin

Auto-generated profile, based on publicly available information

Ilse de Bruin

Department of Developmental Biology, Erasmus MC , Rotterdam

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FBFridtjof Brauns
Fridtjof Brauns
LCLeila M. Iñigo de la Cruz
Leila M. Iñigo de la Cruz
WDWerner K.-G. Daalman
Werner K.-G. Daalman
IBIlse de Bruin
Ilse de Bruin
JHJacob Halatek
Jacob Halatek
EFErwin Frey
Erwin Frey
How can a self-organized cellular function evolve, adapt to perturbations, and acquire new sub-functions? To make progress in answering these basic questions of evolutionary cell biology, we analyze, as a concrete example, the cell polarity machinery of Saccharomyces cerevisiae. This cellular module exhibits an intriguing resilience: it remains operational under genetic perturbations and recovers quickly and reproducibly from the deletion of one of its key components. Using a combination of modeling, conceptual theory, and experiments, we propose that multiple, redundant self-organization mechanisms coexist within the protein network underlying cell polarization and are responsible for the module’s resilience and adaptability. Based on our mechanistic understanding of polarity establishment, we hypothesize that scaffold proteins, by introducing new connections in the existing network, can increase the redundancy of mechanisms and thus increase the evolvability of other network components. Moreover, our work gives a perspective on how a complex, redundant cellular module might have evolved from a more rudimental ancestral form.

2 July 2025 in Human Reproduction
Verified
Journal Article
Open access
IBIlse J de Bruin
Ilse J de Bruin
MSMerel M Spaander
Merel M Spaander
SHSimone Harmsen
Simone Harmsen
RERosanne Edelenbosch
Rosanne Edelenbosch
MPM.C (Corrette) Ploem
M.C (Corrette) Ploem
ADAna M Pereira Daoud
Ana M Pereira Daoud
Stem cell-derived (SCD)-gametes derived from induced or autologous (i.e. patient-specific) cells may help mitigate human fertility problems caused by physiological or social factors in the (near) future. While this technology is still in its infancy, recent advancements with SCD-gametes generated from mouse pluripotent stem cells have led some researchers to expect—and investors to anticipate—the clinical introduction of human gametes derived from induced pluripotent stem cells (iPSCD-gametes) within two decades. However, it remains to be investigated how realistic these expectations are, and how they would balance against careful consideration of technical, ethical, legal, and societal aspects, including—but not limited to—safety and effectiveness. This mini-review aims to encourage that investigation by providing a brief overview of the state-of-the-art and highlighting the breadth of issues involved in the potential clinical introduction of human iPSCD-gametes. These issues emerge before (Stage 1), during (Stage 2), and after (Stage 3) clinical trials, and are discussed in that order. Issues discussed in the context of Stage 1 suggest that gathering the evidence required to preclinically assess the safety of human iPSCD-gametes will be time-consuming and require parallel experiments with sensitive research materials. Issues discussed in the context of Stage 2 suggest that it might take several years for human iPSCD-gametes to transition through distinct clinical trial phases, and that inevitable (and unforeseeable) variations in the quality of human iPSCD-gametes are likely to further slow this down. Finally, issues discussed in the context of Stage 3 suggest that offering human iPSCD-gametes clinically will require addressing questions of accountability and monitoring, some of which might be difficult to formalize by law. Combined, these findings suggest that a responsible clinical introduction of human iPSCD-gametes may take considerably longer than expected, underscoring the importance of transdisciplinary collaborations with a broad range of stakeholders to make well-informed and well-considered choices about their development and application.

4 September 2025 in Human Reproduction Open
Verified
Journal Article
Open access
MSMadalena Vaz Santos
Madalena Vaz Santos
IBIlse J de Bruin
Ilse J de Bruin
NDNina Dartée
Nina Dartée
MLMathangi Lakshmipathi
Mathangi Lakshmipathi
GHGeert Hamer
Geert Hamer
SLSusana Chuva De Sousa Lopes
Susana Chuva De Sousa Lopes
STUDY QUESTION: How do the methods and outcomes of established protocols to specify human primordial germ cell-like cells (hPGCLCs) in vitro compare to each other? SUMMARY ANSWER: All analyzed protocols were successful in generating hPGCLCs, and a few were able to induce further germ cell maturation. WHAT IS KNOWN ALREADY: There are a variety of protocols for generating hPGCLCs in vitro, each with its own advantages and disadvantages. To date no comparison has been made, hindering the practical application of in vitro-derived hPGCLCs in research and the advancement toward generating mature germ cells. STUDY DESIGN, SIZE, DURATION: For this scoping review, a systematic search for protocols was conducted in the databases Scopus and Web of Science, including publications since 2010. Search terms included human, differentiation/specification/induction, germ cell/oogonia/spermatogonia, and primordial. PARTICIPANTS/MATERIALS, SETTING, METHODS: Two separate authors performed the database search according to the inclusion/exclusion criteria. The data regarding the materials and methods as well as results of the included articles were extracted and organized based on protocol (cell type and culture system) and outcome. MAIN RESULTS AND THE ROLE OF CHANCE: A systematic search revealed 32 articles describing the generation of hPGCLCs. Of these, 24 articles contained an original hPGCLC differentiation protocol and 8 articles provided an extension of a previously published protocol. The extension protocols focused either on extending hPGCLC culture or maturing hPGCLCs further. The articles were compared regarding protocol methods and differentiation outcomes. The data showed that differentiation in 2D or 3D, in the presence of bone morphogenetic protein 4 (BMP4) (or retinoic acid), activated the WNT and NODAL signaling pathways to induce hPGCLCs. Further maturation (based on gene expression) was also achieved, depending on the inclusion of subsequent differentiation steps. The 2D culture systems showed high efficiency and scalability, while the 3D culture systems were more suitable for germ cell maturation purposes. Further improvements would include a deeper assessment of epigenetic and gene expression, functional analyses, and use of multiple cell lines to reflect protocol versatility. LIMITATIONS, REASONS FOR CAUTION: Only literature has been compared; no extensive experimental comparison or a meta-analysis was performed due to the heterogeneity in outcome measurements. WIDER IMPLICATIONS OF THE FINDINGS: This review offers a comparison of hPGCLC differentiation protocols and aims to aid researchers in selecting appropriate protocols and making informed modifications to the culture conditions to achieve efficient germ cell differentiation. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by ZonMW (PSIDER 10250022120001) and by the Novo Nordisk Foundation (reNEW NNF21CC0073729). The authors declare no conflicts of interest. REGISTRATION NUMBER: N/A.

28 June 2025 in Human Reproduction Update
Verified
Journal Article
Open access
MLMathangi Lakshmipathi
Mathangi Lakshmipathi
NDNina Dartée
Nina Dartée
APArina Puchkina
Arina Puchkina
MSMadalena Vaz Santos
Madalena Vaz Santos
IBIlse J de Bruin
Ilse J de Bruin
WBWilly M Baarends
Willy M Baarends
BACKGROUND: The gonadal somatic niche is crucial for sex determination and gamete formation throughout the human life cycle. However, key steps in gonadal somatic lineage differentiation occur during embryonic and foetal development, making them difficult to study in humans. In vitro differentiation models are therefore needed to investigate gonadal development, support in vitro gametogenesis, and study infertility. A comprehensive overview of gonadal somatic niche differentiation, both in vivo and in vitro, is thus crucial. OBJECTIVE AND RATIONALE: This review connects in vivo knowledge with in vitro differentiation systems for gonadal somatic niches, predominantly focusing on cell–cell signalling factors. It evaluates existing in vitro protocols for differentiating testicular and ovarian somatic niches, discusses them in the context of in vivo findings, and explores potential advancements in model systems. SEARCH METHODS: A narrative review was conducted after a comprehensive search of the PubMed database through to February 2025; the review focused on search topics including: in vivo gonadal differentiation in humans and mice; in vitro differentiation of human embryonic stem cells or human-induced pluripotent stem cells into gonadal somatic cells (bipotential, Sertoli or granulosa cells); and evidence for the cell–cell signalling factors used in these protocols. OUTCOMES: We investigated various strategies that aim to differentiate human pluripotent stem cells into gonadal somatic cell lineages. These include sequential growth factor differentiation recapitulating all known developmental progenitor stages, directed growth factor differentiation that omitted one or more developmental intermediates, and directed overexpression of key transcription factors. To induce differentiation, the growth factor-based protocols used various cell–cell signalling factors, with some derived from in vivo studies, while others lacked direct in vivo evidence. Despite significant advances in guiding pluripotent stem cells towards gonadal differentiation, challenges remain, such as the limited molecular and functional validation of the generated cell types. Consequently, complete human in vitro gametogenesis through co-culture techniques with pluripotent cell-derived germ cells has not yet been achieved, indicating that full functional maturation of the gonadal niche has not been attained with the current protocols. WIDER IMPLICATIONS: Integrating knowledge on in vivo gonadal development with enhanced differentiation protocols offers the potential to reliably generate the gonadal somatic niche in vitro. This allows for more accurate modelling of the gonad, facilitating deeper insights into the normal and pathological processes involved in gonadal development and germ cell maturation. For example, it could help to identify mechanisms linked to infertility or differences of sex development. Importantly, as many of these models are based on human pluripotent stem cells, they have the potential for personalization, enabling future patient-specific models for studying reproductive disorders and developing tailored fertility treatments. REGISTRATION NUMBER: n/a.

7 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FBFridtjof Brauns
Fridtjof Brauns
LCLeila Iñigo de la Cruz
Leila Iñigo de la Cruz
WDWerner K.-G. Daalman
Werner K.-G. Daalman
IBIlse de Bruin
Ilse de Bruin
JHJacob Halatek
Jacob Halatek
EFErwin Frey
Erwin Frey